MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X102. A total of 30 filers reported holding MYMD PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,543 | -74.3% | 11,052 | -35.0% | 0.00% | – |
| Q2 2023 | $25,507 | +28.4% | 17,004 | +47.2% | 0.00% | – |
| Q1 2023 | $19,869 | +49.6% | 11,552 | 0.0% | 0.00% | – |
| Q4 2022 | $13,284 | -54.2% | 11,552 | +4.5% | 0.00% | – |
| Q3 2022 | $29,000 | +20.8% | 11,052 | 0.0% | 0.00% | – |
| Q2 2022 | $24,000 | -56.4% | 11,052 | -5.7% | 0.00% | – |
| Q1 2022 | $55,000 | -22.5% | 11,719 | 0.0% | 0.00% | – |
| Q4 2021 | $71,000 | -15.5% | 11,719 | +0.0% | 0.00% | – |
| Q3 2021 | $84,000 | – | 11,717 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Shay Capital LLC | 309,178 | $671,000 | 0.14% |
| Taylor & Morgan Wealth Management, LLC | 17,086 | $37,000 | 0.04% |
| Ikarian Capital, LLC | 81,089 | $176,000 | 0.03% |
| Corundum Group, Inc. | 19,600 | $43,000 | 0.03% |
| M Holdings Securities, Inc. | 70,909 | $154,000 | 0.02% |
| Praetorian Wealth Management, Inc. | 15,000 | $32,000 | 0.01% |
| Western Wealth Management, LLC | 27,050 | $115,000 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 1,073,765 | $2,330,000 | 0.01% |
| Virtu Financial LLC | 16,063 | $35,000 | 0.00% |
| SeaCrest Wealth Management, LLC | 6,800 | $15,000 | 0.00% |